Detalhe da pesquisa
1.
Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
N Engl J Med;
386(15): 1432-1442, 2022 04 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35417638
2.
The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim.
Br J Haematol;
204(4): 1143-1145, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38319005
3.
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Lancet;
402(10413): 1648-1659, 2023 11 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37778358
4.
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Blood;
139(10): 1564-1574, 2022 03 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34587251
5.
Adenovirus-associated thrombosis and thrombocytopenia: an emerging anti-PF4 disorder.
Haematologica;
2024 Feb 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38328867
6.
Rare bleeding disorders: Advances in management.
Haemophilia;
30 Suppl 3: 60-69, 2024 Apr.
Artigo
em Holandês
| MEDLINE
| ID: mdl-38494995
7.
Avatrombopag for adults with early versus chronic immune thrombocytopenia.
Am J Hematol;
99(2): 155-162, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38063420
8.
Clinically meaningful improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiency.
Am J Hematol;
2024 May 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38712615
9.
Executive summary of the 14th HHT international scientific conference.
Angiogenesis;
26(Suppl 1): 27-37, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37695357
10.
Novel therapeutics and future directions for refractory immune thrombocytopenia.
Br J Haematol;
203(1): 65-78, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37735554
11.
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or ß-thalassaemia: an open-label, multicentre, phase 2 study.
Lancet;
400(10351): 493-501, 2022 08 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35964609
12.
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
Blood;
137(7): 888-895, 2021 02 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33171488
13.
Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia.
J Thromb Thrombolysis;
56(2): 355-359, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37340288
14.
Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancer.
Cancer;
128(17): 3224-3232, 2022 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35767226
15.
Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia.
Angiogenesis;
25(1): 87-97, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34292451
16.
Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study.
Br J Haematol;
197(3): 359-366, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35179784
17.
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians.
Semin Thromb Hemost;
48(5): 514-528, 2022 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35226946
18.
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
Blood;
136(4): 489-500, 2020 07 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32492712
19.
Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trials.
Pediatr Blood Cancer;
69(3): e29447, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34962697
20.
Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasia.
J Thromb Thrombolysis;
53(3): 708-711, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34694540